Bigfinite Briefing Note
By: Sandra K. Rodriguez, Market Analyst
Axendia was recently briefed by the Executive Management team at Bigfinite following their announcements of their Series B funding and news of their collaboration with Honeywell. With an executive team that has over thirty years of experience in the Life Science industry, Bigfinite helps biotech and pharmaceutical companies establish a lasting, competitive advantage through an agile and effective use of manufacturing data via their GxP-compliant AI/ML SaaS platform. The platform is offered as a single tenant, virtual private cloud for every one of its clients for security and for confidentiality purposes.
“We are not only tech people doing pharma, we are also pharma people doing tech,” began Pep Gubau, CEO at Bigfinite. Manufacturing intelligence is not new; yet it remains a challenge. Pharma, as well as other industries, have dedicated a lot of effort and technology towards this initiative for many years. “We believe manufacturing processes can’t be improved due to an incomplete understanding of operational realities. There are still too many things that contribute to variations in processes that are not well understood. That leads to repeat deviations and the inability to get the root causes of those deviations,” said Claus Abildgren, VP Business Development at Bigfinite.Continue reading